Lannett Co

LCI NYSE
5.90
+0.22
+3.87%
After Hours: 5.90 0 0.00% 16:39 06/26 EDT
Open
5.69
Prev Close
5.68
High
6.04
Low
5.67
Volume
1.01M
Avg Vol (3M)
1.13M
52 Week High
14.70
52 Week Low
3.330
% Turnover
2.56%
Market Cap
232.01M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Lannett Co LCI stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
MORE >

Recently

Name
Price
%Change